These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28726173)

  • 1. Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?
    Zanello M; Roux A; Ursu R; Peeters S; Bauchet L; Noel G; Guyotat J; Le Reste PJ; Faillot T; Litre F; Desse N; Emery E; Petit A; Peltier J; Voirin J; Caire F; Barat JL; Vignes JR; Menei P; Langlois O; Dezamis E; Carpentier A; Dam Hieu P; Metellus P; Pallud J;
    J Neurooncol; 2017 Nov; 135(2):285-297. PubMed ID: 28726173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Treatment Tolerance and Factors Associated with Overall Survival in Elderly Patients with Glioblastoma.
    Zhang C; Wang X; Hao S; Su Z; Zhang P; Li Y; Song G; Yu L; Wang J; Ji N; Xie J; Gao Z
    World Neurosurg; 2016 Nov; 95():77-84. PubMed ID: 27485530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model.
    Audureau E; Chivet A; Ursu R; Corns R; Metellus P; Noel G; Zouaoui S; Guyotat J; Le Reste PJ; Faillot T; Litre F; Desse N; Petit A; Emery E; Lechapt-Zalcman E; Peltier J; Duntze J; Dezamis E; Voirin J; Menei P; Caire F; Dam Hieu P; Barat JL; Langlois O; Vignes JR; Fabbro-Peray P; Riondel A; Sorbets E; Zanello M; Roux A; Carpentier A; Bauchet L; Pallud J;
    J Neurooncol; 2018 Feb; 136(3):565-576. PubMed ID: 29159777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma.
    De Bonis P; Fiorentino A; Anile C; Balducci M; Pompucci A; Chiesa S; Sica G; Lama G; Maira G; Mangiola A
    Clin Neurol Neurosurg; 2013 Jul; 115(7):883-6. PubMed ID: 22959214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice.
    Roux A; Peeters S; Zanello M; Bou Nassif R; Abi Lahoud G; Dezamis E; Parraga E; Lechapt-Zalcmann E; Dhermain F; Dumont S; Louvel G; Chretien F; Sauvageon X; Devaux B; Oppenheim C; Pallud J
    J Neurooncol; 2017 Oct; 135(1):83-92. PubMed ID: 28669011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients.
    Behm T; Horowski A; Schneider S; Bock HC; Mielke D; Rohde V; Stockhammer F
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2142-6. PubMed ID: 23993314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.
    Mohan DS; Suh JH; Phan JL; Kupelian PA; Cohen BH; Barnett GH
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):981-7. PubMed ID: 9869219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).
    Lombardi G; Pace A; Pasqualetti F; Rizzato S; Faedi M; Anghileri E; Nicolotto E; Bazzoli E; Bellu L; Villani V; Fabi A; Ferrazza P; Gurrieri L; Dall'Agata M; Eoli M; Della Puppa A; Pambuku A; D'Avella D; Berti F; Rudà R; Zagonel V
    J Neurooncol; 2015 Nov; 125(2):359-67. PubMed ID: 26423801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma.
    Bertaut A; Truntzer C; Madkouri R; Kaderbhai CG; Derangère V; Vincent J; Chauffert B; Aubriot-Lorton MH; Farah W; Mourier KL; Boidot R; Ghiringhelli F
    Oncotarget; 2016 Oct; 7(43):70948-70958. PubMed ID: 27487142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permeability Surface Area Product Using Perfusion Computed Tomography Is a Valuable Prognostic Factor in Glioblastomas Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide.
    Saito T; Sugiyama K; Ikawa F; Yamasaki F; Ishifuro M; Takayasu T; Nosaka R; Nishibuchi I; Muragaki Y; Kawamata T; Kurisu K
    World Neurosurg; 2017 Jan; 97():21-26. PubMed ID: 27693246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of maximal safe resection for glioblastoma including elderly and low Karnofsky performance status patients: retrospective review at a single institute.
    Uzuka T; Aoki H; Natsumeda M; Takahashi H; Fujii Y
    Neurol Med Chir (Tokyo); 2012; 52(8):570-6. PubMed ID: 22976140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and functional status after resection of recurrent glioblastoma multiforme.
    Barker FG; Chang SM; Gutin PH; Malec MK; McDermott MW; Prados MD; Wilson CB
    Neurosurgery; 1998 Apr; 42(4):709-20; discussion 720-3. PubMed ID: 9574634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival.
    Lee J; Ahn SS; Chang JH; Suh CO
    Yonsei Med J; 2018 Mar; 59(2):194-201. PubMed ID: 29436186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.
    Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY
    Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of post-operative complications associated with repeat resection and BCNU wafer implantation in recurrent glioblastoma.
    Samis Zella MA; Wallocha M; Slotty PJ; Isik G; Hänggi D; Schroeteler J; Ewelt C; Steiger HJ; Sabel M
    Acta Neurochir (Wien); 2014 Feb; 156(2):313-23. PubMed ID: 24287680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of the Karnosky Performance Status throughout life in glioblastoma patients.
    Sacko A; Hou MM; Temgoua M; Alkhafaji A; Marantidou A; Belin C; Mandonnet E; Ursu R; Doridam J; Coman I; Levy-Piedbois C; Carpentier AF
    J Neurooncol; 2015 May; 122(3):567-73. PubMed ID: 25700836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.